Chronic Obstructive Pulmonary Disease Clinical Trial
Official title:
Effects of Hypoxia and Inflammation on Citrulline Synthesis by Ornithine Transcarbamylase in Human Enterocytes
Chronic Obstructive Pulmonary Disease (COPD) is characterized by chronic systemic hypoxia
and low-grade inflammation as well as by an alteration of arginine (ARG) metabolism. As ARG
is synthetized from circulating citrulline (CIT), an alteration of CIT homeostasis,
particularly its production by ornithine transcarbamylase (OCT) in small intestine could be
involved. We hypothesized that hypoxia +/- inflammation, classically associated to COPD, has
effects on OCT regulation in enterocytes.
This study aims at exploring the effects of hypoxia and inflammation on the production of
citrulline by ornithine transcarbamylase (OTC) activity in enterocytes from explant cultures
of duodenal tissue.
Citrulline is an amino-acid almost exclusively released by the small intestine after its
synthesis from glutamine by the OTC in enterocytes. Citrulline from the small intestine is
released into the portal vena and, because it does not enter hepatocytes, it reaches the
systemic circulation to be metabolized in arginine by kidneys. By this way, is an important
source of endogenous ARG. Moreover, evidence suggests that circulating citrulline could have
a direct action on the regulation of muscle protein synthesis. Therefore, the administration
of citrulline might be an interesting nutritional strategy to preserve or restore muscle
mass and function. Muscle mass is a determinant of respiratory function and muscle weakness
explains for a large part morbidity and mortality in patients suffering from Chronic
Obstructive Pulmonary Disease (COPD).
Evidence suggests that citrulline plasmatic levels would be lower in several states
involving systemic inflammation and hypoxia. Indeed, it has been observed in rats that
hypoxia leads to a sharp decline in plasma CIT concentration and also in human
(hypocitrullinemia has been observed in Intensive Care Unit patients and in subjects
suffering from sepsis and trauma) but the cause of relationship is not yet established.
Therefore, it may be supposed that a decreased plasma CIT level could be responsible for a
decrease in de novo ARG synthesis leading to an impairment of NO production (endothelial
dysfunction) in these pathological situations.
Because chronic hypoxia and systemic inflammation are both systemic traits of patients
suffering from COPD, the fact that hypoxia and/or systemic inflammation might directly
affect OCT, decreasing intestinal citrulline production which, in turn, could contribute to
endothelial dysfunction and muscle weakness is considered.
In order to explore this hypothesis, the potential consequences of hypoxia and inflammation
(alone or in association) on citrulline synthesis by the OCT in human enterocytes will be
determined, thanks to an "explant" culture model of duodenal tissue. Duodenal biopsies will
be removed during oesophago-gastro-duodenoscopies performed in the Hepato-gastro-enterology
unit of Grenoble University Hospital, among patients expected to undergo a gastroscopy for
any diagnostic purpose. 30 patients will be selected during a period of 6 months. After
complete information and written agreement, 8 biopsy specimens will be removed from the
duodenum of each patient and processed for organ culture.
Then, duodenal biopsies will be incubated in the presence or not of cytokines and exposed or
not to hypoxia. Indeed, 4 groups will be constituted: a control group (no stimulus), a group
exposed to hypoxic conditions, a group exposed to inflammatory conditions (cytokines) and a
group exposed to both hypoxic an inflammatory conditions.
As primary endpoint, for each group, the OTC activity and the citrulline production in the
culture medium will be studied.
;
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05102305 -
A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
|
||
Completed |
NCT01867762 -
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Recruiting |
NCT05562037 -
Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA
|
N/A | |
Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
Completed |
NCT03089515 -
Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust
|
N/A | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT05552833 -
Pulmonary Adaptive Responses to HIIT in COPD
|
N/A | |
Recruiting |
NCT05835492 -
A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
|
||
Recruiting |
NCT05631132 -
May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases?
|
N/A | |
Completed |
NCT03244137 -
Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
|
||
Not yet recruiting |
NCT03282526 -
Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease
|
N/A | |
Completed |
NCT02546700 -
A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 2 | |
Withdrawn |
NCT04446637 -
Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD
|
Phase 3 | |
Completed |
NCT04535986 -
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
|
Phase 3 | |
Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
Completed |
NCT03256695 -
Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT03295474 -
Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
|
||
Withdrawn |
NCT04042168 -
Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT03414541 -
Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Completed |
NCT02552160 -
DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy
|